Also known as: Post-Traumatic Stress Disorder
A trauma-related diagnosis involving re-experiencing, avoidance, negative cognitions, and hyperarousal symptoms persisting beyond one month after a traumatic event. EMDR and CBT are first-line treatments per VA, WHO, and APA guidelines.
PTSD is a trauma-related diagnosis recognised across DSM-5-TR and ICD-11. The diagnostic criteria require exposure to a traumatic event followed by symptoms across four clusters persisting beyond one month: re-experiencing (intrusive memories, flashbacks, nightmares), avoidance (of trauma reminders), negative alterations in cognitions and mood (persistent shame, guilt, distorted self-blame), and alterations in arousal and reactivity (hypervigilance, sleep disruption, irritability).
First-line treatments per VA/DoD, WHO, and APA guidelines: EMDR and trauma-focused CBT (including Cognitive Processing Therapy and Prolonged Exposure). Effect sizes are large. 8 to 12 sessions typically reduce PTSD diagnoses to subclinical levels for single-incident trauma.
Body-based and complementary approaches with strong evidence:
For complex PTSD (sustained or repeated traumatic exposure), see the dedicated definition. The phase-based approach combining body-based stabilisation, trauma processing, and identity-level integration consistently outperforms single-modality approaches.
Combined approaches: pairing EMDR or trauma-focused CBT with body-based work (yoga, somatic experiencing, EFT) consistently outperforms either alone for the substantial subgroup of patients who respond partially to first-line treatment.
Psychedelic-assisted therapy: MDMA-assisted therapy showed strong RCT effects for PTSD in Phase 3 trials. Psilocybin shows promise for treatment-resistant depression. Both remain in clinical trial pathways in most countries.
Severe acute PTSD with suicide risk requires immediate clinical intervention regardless of modality preference.
Glossary31 terms covering modalities, mechanisms, and conditions